NUREXONE BIOLOGIC INC (NRX.CA) Stock Price, Quote, News and Overview

What is the stock price of NUREXONE BIOLOGIC INC today?

The current stock price of NRX.CA is 0.55 CAD. The price decreased by -1.79% in the last trading session.

What is the ticker symbol for NUREXONE BIOLOGIC INC stock?

The exchange symbol of NUREXONE BIOLOGIC INC is NRX and it is listed on the TSX Venture Exchange exchange.

On which exchange is NRX.CA stock listed?

NRX.CA stock is listed on the TSX Venture Exchange exchange.

What is the price forecast or stock price prediction for NUREXONE BIOLOGIC INC stock?

9 analysts have analysed NRX.CA and the average price target is 2.89 CAD. This implies a price increase of 424.84% is expected in the next year compared to the current price of 0.55. Check the NUREXONE BIOLOGIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is NUREXONE BIOLOGIC INC worth?

NUREXONE BIOLOGIC INC (NRX.CA) has a market capitalization of 40.78M CAD. This makes NRX.CA a Nano Cap stock.

How many employees does NUREXONE BIOLOGIC INC have?

NUREXONE BIOLOGIC INC (NRX.CA) currently has 12 employees.

What are the support and resistance levels for NUREXONE BIOLOGIC INC (NRX.CA) stock?

NUREXONE BIOLOGIC INC (NRX.CA) has a support level at 0.54 and a resistance level at 0.55. Check the full technical report for a detailed analysis of NRX.CA support and resistance levels.

Should I buy NUREXONE BIOLOGIC INC (NRX.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of NRX.CA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of NRX.CA, evaluating the profitability, health, valuation and growth aspects
• NUREXONE BIOLOGIC INC (NRX.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• NUREXONE BIOLOGIC INC (NRX.CA) Sales and EPS estimates to see what analysts future expectations are.
• NUREXONE BIOLOGIC INC (NRX.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• NUREXONE BIOLOGIC INC (NRX.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
• NUREXONE BIOLOGIC INC (NRX.CA) Stock Chart to make your own analysis
• NUREXONE BIOLOGIC INC (NRX.CA) Latest news and press-releases to stay up to date.

Does NUREXONE BIOLOGIC INC (NRX.CA) stock pay dividends?

NRX.CA does not pay a dividend.

When does NUREXONE BIOLOGIC INC (NRX.CA) report earnings?

NUREXONE BIOLOGIC INC (NRX.CA) will report earnings on 2025-03-27.

What is the Price/Earnings (PE) ratio of NUREXONE BIOLOGIC INC (NRX.CA)?

NUREXONE BIOLOGIC INC (NRX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).

ChartMill assigns a fundamental rating of 1 / 10 to NRX.CA. The financial health of NRX.CA is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months NRX.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 20.07% compared to the year before.

ChartMill assigns a Buy % Consensus number of 84% to NRX.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.